Galectin Therapeutics Inc
GALT· Nasdaq
GALTGalectin Therapeutics Inc
Filed May 15, 2017 · 10-Q · 45 days after period end · 0001193125-17-169790
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$4.94M | -$6.80M | -$4.83M | -$5.11M |
| EPS Diluted | -$0.15 | -$0.24 | -$0.22 | -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Galectin Therapeutics Inc · CIK 1133416 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 15, 2017 · 45 d after period end
